1. Home
  2. JOB vs AYTU Comparison

JOB vs AYTU Comparison

Compare JOB & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GEE Group Inc.

JOB

GEE Group Inc.

HOLD

Current Price

$0.22

Market Cap

25.2M

ML Signal

HOLD

Logo Aytu BioPharma Inc.

AYTU

Aytu BioPharma Inc.

HOLD

Current Price

$2.17

Market Cap

27.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JOB
AYTU
Founded
1893
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.2M
27.4M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
JOB
AYTU
Price
$0.22
$2.17
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$9.33
AVG Volume (30 Days)
156.0K
25.1K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$96,504,000.00
$27,632,080.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$43.75
P/E Ratio
N/A
N/A
Revenue Growth
N/A
277.47
52 Week Low
$0.17
$1.65
52 Week High
$0.28
$3.07

Technical Indicators

Market Signals
Indicator
JOB
AYTU
Relative Strength Index (RSI) 50.89 46.15
Support Level $0.21 $2.11
Resistance Level $0.26 $2.31
Average True Range (ATR) 0.01 0.07
MACD 0.00 0.00
Stochastic Oscillator 84.35 28.32

Price Performance

Historical Comparison
JOB
AYTU

About JOB GEE Group Inc.

GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: